Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
The report details the trend, potential and market size of Metabolic Disorders Drugs market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.
The first part (Chapter1-7) mainly covers the qualitative analysis of Metabolic Disorders Drugsmarket, defines the market attractiveness level of Metabolic Disorders Drugs market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.
The second part (Chapter8-12), based on the segmentation of Metabolic Disorders Drugs industry, describes the types of Metabolic Disorders Drugs market, the applications of major players and the market size, and deeply analyzes the current situation of the global Metabolic Disorders Drugs market and the development prospects and opportunities of Metabolic Disorders Drugs industry.
The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.
As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Metabolic Disorders Drugs market in Chapter 13.
By Player:
Pronutria Biosciences
Eternygen
Zealand Pharma
CellCentric
Outpost Medicine
Mitobridge
Anchor Therapeutics
Rhythm
Zafgen
Verva Pharmaceuticals
PerkinElmer
MedGenome
Nimbus Therapeutics
OxThera
Exelixis, Inc
Biophytis
By Type:
Tablet
Injection
By End-User:
Diabetes
Disorders of the Thyroid and Pituitary Gland
Other
By Geography:
-
United States
-
Europe
-
China
-
Japan
-
India
-
South Korea
TABLE OF CONTENT
1 Introduction
-
1.1 Market Definition
-
1.2 Market Segment Analysis
-
1.3 Market Size 2022
-
1.4 Metabolic Disorders Drugs Market Outlook: Forecast for 2022 - 2028
-
1.5 Pricing Analysis
2 Executive Summary
3 Metabolic Disorders Drugs Market Lineage Outlook
-
3.1 Parent Market Outlook
-
3.2 Related/Ancillary Market Outlook
-
3.3 Penetration & Growth Prospect Mapping, 2022
4 Market Analysis Tools: Porter's Five Forces
-
4.1 Supplier Power
-
4.2 Buyer Power
-
4.3 Substitution Threat
-
4.4 Threat of New Entrants
-
4.5 Competitive Rivalry
5 Metabolic Disorders Drugs Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)
-
5.1 Political/Legal Landscape
-
5.2 Economic Landscape
-
5.3 Social Landscape
-
5.4 Technology Landscape
6 Metabolic Disorders Drugs Market - Value Chain Analysis
-
6.1 Industry's Value Chain Analysis
-
6.2 Product Life Cycle
-
6.3 User Perspective Analysis
7 Region and Country-wise Metabolic Disorders Drugs Market Analysis and Outlook to 2022
-
7.1 Global Metabolic Disorders Drugs Consumption (2017-2022)
-
7.2 United States Metabolic Disorders Drugs Consumption (2017-2022)
-
7.3 Europe Metabolic Disorders Drugs Consumption (2017-2022)
-
7.4 China Metabolic Disorders Drugs Consumption (2017-2022)
-
7.5 Japan Metabolic Disorders Drugs Consumption (2017-2022)
-
7.6 India Metabolic Disorders Drugs Consumption (2017-2022)
-
7.7 South Korea Metabolic Disorders Drugs Consumption (2017-2022)
8 Region and Country-wise Metabolic Disorders Drugs Market Analysis and Outlook to 2028
-
8.1 Global Metabolic Disorders Drugs Consumption Forecast (2022-2028)
-
8.2 United States Metabolic Disorders Drugs Consumption Forecast (2022-2028)
-
8.3 Europe Metabolic Disorders Drugs Consumption Forecast (2022-2028)
-
8.4 China Metabolic Disorders Drugs Consumption Forecast (2022-2028)
-
8.5 Japan Metabolic Disorders Drugs Consumption Forecast (2022-2028)
-
8.6 India Metabolic Disorders Drugs Consumption Forecast (2022-2028)
-
8.7 South Korea Metabolic Disorders Drugs Consumption Forecast (2022-2028)
9 Global Metabolic Disorders Drugs Market Outlook by Types and Applications to 2022
-
9.1 Global Metabolic Disorders Drugs Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global Tablet Consumption and Growth Rate (2017-2022)
-
9.1.2 Global Injection Consumption and Growth Rate (2017-2022)
-
9.2 Global Metabolic Disorders Drugs Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Diabetes Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Disorders of the Thyroid and Pituitary Gland Consumption and Growth Rate (2017-2022)
-
9.2.3 Global Other Consumption and Growth Rate (2017-2022)
10 Global Metabolic Disorders Drugs Market Outlook by Types and Applications to 2028
-
10.1 Global Metabolic Disorders Drugs Consumption Forecast and Growth Rate by Type (2022-2028)
-
10.1.1 Global Tablet Consumption Forecast and Growth Rate (2022-2028)
-
10.1.2 Global Injection Consumption Forecast and Growth Rate (2022-2028)
-
10.2 Global Metabolic Disorders Drugs Consumption Forecast and Growth Rate by Application (2022-2028)
-
10.2.1 Global Diabetes Consumption Forecast and Growth Rate (2022-2028)
-
10.2.2 Global Disorders of the Thyroid and Pituitary Gland Consumption Forecast and Growth Rate (2022-2028)
-
10.2.3 Global Other Consumption Forecast and Growth Rate (2022-2028)
11 Global Metabolic Disorders Drugs Import and Export Analysis (Top 5 Countries)
-
11.1 Global Metabolic Disorders Drugs Import by Region (Top 5 Countries) (2017-2028)
-
11.2 Global Metabolic Disorders Drugs Export by Region (Top 5 Countries) (2017-2028)
12 Coronavirus Disease (COVID-19) Impact
-
12.1 Industry Impact Analysis
-
12.2 Metabolic Disorders Drugs Market Outlook to 2028 - COVID-19 Affected Forecasts
13 Competition Matrix
-
13.1 Target Markets
-
13.2 Comprehensive Analysis of Products in Competitive Markets
14 Global Metabolic Disorders Drugs Market Competitive Analysis
-
14.1 Pronutria Biosciences
-
14.1.1 Pronutria Biosciences Company Details
-
14.1.2 Pronutria Biosciences Metabolic Disorders Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.1.3 Pronutria Biosciences Metabolic Disorders Drugs Product and Service
-
14.2 Eternygen
-
14.2.1 Eternygen Company Details
-
14.2.2 Eternygen Metabolic Disorders Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.2.3 Eternygen Metabolic Disorders Drugs Product and Service
-
14.3 Zealand Pharma
-
14.3.1 Zealand Pharma Company Details
-
14.3.2 Zealand Pharma Metabolic Disorders Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.3.3 Zealand Pharma Metabolic Disorders Drugs Product and Service
-
14.4 CellCentric
-
14.4.1 CellCentric Company Details
-
14.4.2 CellCentric Metabolic Disorders Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.4.3 CellCentric Metabolic Disorders Drugs Product and Service
-
14.5 Outpost Medicine
-
14.5.1 Outpost Medicine Company Details
-
14.5.2 Outpost Medicine Metabolic Disorders Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.5.3 Outpost Medicine Metabolic Disorders Drugs Product and Service
-
14.6 Mitobridge
-
14.6.1 Mitobridge Company Details
-
14.6.2 Mitobridge Metabolic Disorders Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.6.3 Mitobridge Metabolic Disorders Drugs Product and Service
-
14.7 Anchor Therapeutics
-
14.7.1 Anchor Therapeutics Company Details
-
14.7.2 Anchor Therapeutics Metabolic Disorders Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.7.3 Anchor Therapeutics Metabolic Disorders Drugs Product and Service
-
14.8 Rhythm
-
14.8.1 Rhythm Company Details
-
14.8.2 Rhythm Metabolic Disorders Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.8.3 Rhythm Metabolic Disorders Drugs Product and Service
-
14.9 Zafgen
-
14.9.1 Zafgen Company Details
-
14.9.2 Zafgen Metabolic Disorders Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.9.3 Zafgen Metabolic Disorders Drugs Product and Service
-
14.10 Verva Pharmaceuticals
-
14.10.1 Verva Pharmaceuticals Company Details
-
14.10.2 Verva Pharmaceuticals Metabolic Disorders Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.10.3 Verva Pharmaceuticals Metabolic Disorders Drugs Product and Service
-
14.11 PerkinElmer
-
14.11.1 PerkinElmer Company Details
-
14.11.2 PerkinElmer Metabolic Disorders Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.11.3 PerkinElmer Metabolic Disorders Drugs Product and Service
-
14.12 MedGenome
-
14.12.1 MedGenome Company Details
-
14.12.2 MedGenome Metabolic Disorders Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.12.3 MedGenome Metabolic Disorders Drugs Product and Service
-
14.13 Nimbus Therapeutics
-
14.13.1 Nimbus Therapeutics Company Details
-
14.13.2 Nimbus Therapeutics Metabolic Disorders Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.13.3 Nimbus Therapeutics Metabolic Disorders Drugs Product and Service
-
14.14 OxThera
-
14.14.1 OxThera Company Details
-
14.14.2 OxThera Metabolic Disorders Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.14.3 OxThera Metabolic Disorders Drugs Product and Service
-
14.15 Exelixis, Inc
-
14.15.1 Exelixis, Inc Company Details
-
14.15.2 Exelixis, Inc Metabolic Disorders Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.15.3 Exelixis, Inc Metabolic Disorders Drugs Product and Service
-
14.16 Biophytis
-
14.16.1 Biophytis Company Details
-
14.16.2 Biophytis Metabolic Disorders Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.16.3 Biophytis Metabolic Disorders Drugs Product and Service
15 Appendix
TABLE OF CHARTS
-
Table Definition of Metabolic Disorders Drugs
-
Figure Metabolic Disorders Drugs Picture
-
Table Global Metabolic Disorders Drugs Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Metabolic Disorders Drugs Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Metabolic Disorders Drugs Market: Year-over-year Growth 2022 - 2028 (%)
-
Table Parent Market Analysis
-
Figure Parent Market Price
-
Table Related/Ancillary Market Outlook Analysis
-
Table Supplier Power Analysis
-
Table Buyer Power Analysis
-
Table Substitution Threat Analysis
-
Table Threat of New Entrants Analysis
-
Table Competitive Rivalry Analysis
-
Figure Global Metabolic Disorders Drugs Consumption by Country (2017-2022)
-
Figure United States Metabolic Disorders Drugs Consumption and Growth Rate (2017-2022)
-
Table Europe Metabolic Disorders Drugs Consumption and Growth Rate (2017-2022)
-
Figure China Metabolic Disorders Drugs Consumption and Growth Rate (2017-2022)
-
Figure Japan Metabolic Disorders Drugs Consumption and Growth Rate (2017-2022)
-
Figure India Metabolic Disorders Drugs Consumption and Growth Rate (2017-2022)
-
Figure South Korea Metabolic Disorders Drugs Consumption and Growth Rate (2017-2022)
-
Figure Global Metabolic Disorders Drugs Consumption Forecast by Country (2022-2028)
-
Figure United States Metabolic Disorders Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Metabolic Disorders Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure China Metabolic Disorders Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Metabolic Disorders Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Metabolic Disorders Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Metabolic Disorders Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Tablet Consumption and Growth Rate (2017-2022)
-
Figure Global Injection Consumption and Growth Rate (2017-2022)
-
Figure Global Diabetes Consumption and Growth Rate (2017-2022)
-
Figure Global Disorders of the Thyroid and Pituitary Gland Consumption and Growth Rate (2017-2022)
-
Figure Global Other Consumption and Growth Rate (2017-2022)
-
Figure Global Tablet Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Injection Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Diabetes Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Disorders of the Thyroid and Pituitary Gland Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Other Consumption Forecast and Growth Rate (2022-2028)
-
Table Global Metabolic Disorders Drugs Import by Region (Top 5 Countries) (2017-2028)
-
Table Global Metabolic Disorders Drugs Export by Region (Top 5 Countries) (2017-2028)
-
Table Pronutria Biosciences (Foundation Year, Company Profile and etc.)
-
Table Pronutria Biosciences Metabolic Disorders Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Pronutria Biosciences Metabolic Disorders Drugs Product and Service
-
Table Eternygen (Foundation Year, Company Profile and etc.)
-
Table Eternygen Metabolic Disorders Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Eternygen Metabolic Disorders Drugs Product and Service
-
Table Zealand Pharma (Foundation Year, Company Profile and etc.)
-
Table Zealand Pharma Metabolic Disorders Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Zealand Pharma Metabolic Disorders Drugs Product and Service
-
Table CellCentric (Foundation Year, Company Profile and etc.)
-
Table CellCentric Metabolic Disorders Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table CellCentric Metabolic Disorders Drugs Product and Service
-
Table Outpost Medicine (Foundation Year, Company Profile and etc.)
-
Table Outpost Medicine Metabolic Disorders Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Outpost Medicine Metabolic Disorders Drugs Product and Service
-
Table Mitobridge (Foundation Year, Company Profile and etc.)
-
Table Mitobridge Metabolic Disorders Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Mitobridge Metabolic Disorders Drugs Product and Service
-
Table Anchor Therapeutics (Foundation Year, Company Profile and etc.)
-
Table Anchor Therapeutics Metabolic Disorders Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Anchor Therapeutics Metabolic Disorders Drugs Product and Service
-
Table Rhythm (Foundation Year, Company Profile and etc.)
-
Table Rhythm Metabolic Disorders Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Rhythm Metabolic Disorders Drugs Product and Service
-
Table Zafgen (Foundation Year, Company Profile and etc.)
-
Table Zafgen Metabolic Disorders Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Zafgen Metabolic Disorders Drugs Product and Service
-
Table Verva Pharmaceuticals (Foundation Year, Company Profile and etc.)
-
Table Verva Pharmaceuticals Metabolic Disorders Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Verva Pharmaceuticals Metabolic Disorders Drugs Product and Service
-
Table PerkinElmer (Foundation Year, Company Profile and etc.)
-
Table PerkinElmer Metabolic Disorders Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table PerkinElmer Metabolic Disorders Drugs Product and Service
-
Table MedGenome (Foundation Year, Company Profile and etc.)
-
Table MedGenome Metabolic Disorders Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table MedGenome Metabolic Disorders Drugs Product and Service
-
Table Nimbus Therapeutics (Foundation Year, Company Profile and etc.)
-
Table Nimbus Therapeutics Metabolic Disorders Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Nimbus Therapeutics Metabolic Disorders Drugs Product and Service
-
Table OxThera (Foundation Year, Company Profile and etc.)
-
Table OxThera Metabolic Disorders Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table OxThera Metabolic Disorders Drugs Product and Service
-
Table Exelixis, Inc (Foundation Year, Company Profile and etc.)
-
Table Exelixis, Inc Metabolic Disorders Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Exelixis, Inc Metabolic Disorders Drugs Product and Service
-
Table Biophytis (Foundation Year, Company Profile and etc.)
-
Table Biophytis Metabolic Disorders Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Biophytis Metabolic Disorders Drugs Product and Service
-
